visken withdrawn form
novartis pharmaceuticals uk ltd - pindolol - withdrawn form
visken tablets 15 milligram
novartis pharmaceuticals uk ltd - pindolol - tablets - 15 milligram
visken tablets 15 milligram
novartis pharmaceuticals uk ltd - pindolol - tablets - 15 milligram
visken tablets 5mg
novartis pharmaceuticals australia pty ltd - pindolol -
viskaldix
novartis new zealand ltd - clopamide 5mg; pindolol 10mg; - tablet - active: clopamide 5mg pindolol 10mg excipient: lactose monohydrate magnesium stearate maize starch
ridazin 10 mg
taro pharmaceutical industries ltd - thioridazine hydrochloride - film coated tablets - thioridazine hydrochloride 10 mg - thioridazine - ridazin is indicated only for schizophrenic patients who fail to show an acceptable response to adequate courses of treatment with other antipsychotic drugs, either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects. thioridazine has not been systematically evaluated in controlled trials in treatment refractory schizophrenic patients and its efficacy in such patients is unknown.
ridazin 100 mg
taro pharmaceutical industries ltd - thioridazine hydrochloride - film coated tablets - thioridazine hydrochloride 100 mg - thioridazine - ridazin is indicated only for schizophrenic patients who fail to show an acceptable response to adequate courses of treatment with other antipsychotic drugs, either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects. thioridazine has not been systematically evaluated in controlled trials in treatment refractory schizophrenic patients and its efficacy in such patients is unknown.
ridazin 25 mg
taro pharmaceutical industries ltd - thioridazine hydrochloride - film coated tablets - thioridazine hydrochloride 25 mg - thioridazine - ridazin is indicated only for schizophrenic patients who fail to show an acceptable response to adequate courses of treatment with other antipsychotic drugs, either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects. thioridazine has not been systematically evaluated in controlled trials in treatment refractory schizophrenic patients and its efficacy in such patients is unknown.
viskaldix 10mg+5mg tab tablet
novartis - clopamide, pindolol - tablet - 10, 5 mg
norvir
abbvie pty ltd - ritonavir -